The Regenerative Rehabilitation Paradox: A Systematic Review of Functional Endpoint Heterogeneity in Stem Cell Clinical Trials
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.124_70259 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Diana Jia.
Abstract (Originalsprache)
Background and/or Objectives: This study evaluates the "Rehabilitation Gap" in MUSE cell trials, identifying discrepancies between histological success and functional reporting.It addresses the "Regenerative Rehabilitation Paradox" where biological repair fails to achieve measurable improvements in patient independence.
Design
A systematic review and qualitative synthesis was conducted following PRISMA-P protocols.Peerreviewed studies (2010-2025) involving MUSE cell interventions for neurologic, musculoskeletal, and systemic impairments were analyzed.Outcome measures were stratified by the International Classification of Functioning, Disability and Health (ICF) into impairment, activity, and participation-based levels.
Setting
A translational review conducted across preclinical and early-phase clinical data environments, targeting neurologic, musculoskeletal, and systemic impairments within acute, subacute, and chronic rehabilitation frameworks.
Participants
Peer-reviewed clinical studies (2010-2025) involving MUSE cell interventions for neurologic, musculoskeletal, and systemic impairments.Analysis included human-centric functional data across acute and chronic injury models.
Interventions
This is a systematic review of existing translational data and early-phase clinical trials.The focus is on the retrospective analysis of multilineagedifferentiating stress-enduring (MUSE) cell delivery protocols and their subsequent integration with varied physical medicine and rehabilitation interventions.Main Outcome Measures: Outcome measures were stratified via ICF levels: 1 (Impairment), 2 (Activity, e.g., FIM), and 3 (Participation).Analysis prioritized correlations between histological survival and functional recovery across neurologic and musculoskeletal domains.
Results
Analysis reveals that while MUSE cells demonstrate high survival and site-specific differentiation, functional outcomes remain secondary to surrogate
Zitieren
APA
Jia, D. (2026). The Regenerative Rehabilitation Paradox: A Systematic Review of Functional Endpoint Heterogeneity in Stem Cell Clinical Trials. PM&R, 18(S3). https://doi.org/10.1002/pmrj.124_70259
Vancouver
Jia D. The Regenerative Rehabilitation Paradox: A Systematic Review of Functional Endpoint Heterogeneity in Stem Cell Clinical Trials. PM&R. 2026;18(S3). doi:10.1002/pmrj.124_70259
BibTeX
@article{Jia2026,
author = {Jia, Diana},
title = {The Regenerative Rehabilitation Paradox: A Systematic Review of Functional Endpoint Heterogeneity in Stem Cell Clinical Trials},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.124_70259}
}
EUVIMED